» Articles » PMID: 18922986

Chronic Kidney Disease in the United States: a Public Policy Imperative

Overview
Specialty Nephrology
Date 2008 Oct 17
PMID 18922986
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: In the past decade, a crisis in nephrology has slowly emerged in the areas of both clinical care and public policy. In 2003, the Council of American Kidney Societies (CAKS) identified 19 barriers to improved patient outcomes in chronic kidney disease (CKD).

Design, Setting, Participants, & Measurements: Site visits and in-depth telephone interviews were conducted with 15 nephrologists focusing on current issues with identifying and treating patients with CKD. The qualitative analyses were considered in the context of CAKS-identified barriers to assess the present state of nephrology care and provide a foundation for a more detailed quantitative CKD project potential implications for advancing nephrology-related health policy.

Results: Despite new evidence-based therapies to slow, stop, or reverse the progression of CKD to ESRD as well as premature cardiovascular disease, major systemic barriers continue to limit the implementation of this body of evidence at the level of the nephrology practice. Key factors include under- or uninsurance, unstructured medical care systems, and lack of enabling public policies.

Conclusions: The crisis of nephrology is embedded within the unresolved duress of the ability to provide quality early intervention juxtaposed upon inadequate reimbursement for clinical care and procedures, unfunded mandates for information technology systems, and organizational inconsistencies between nephrology and other specialties. We believe now is the time for the renal community and related stakeholders to unite in an effort to address the clinical, financial, and public policy issues that will enable the delivery of appropriate CKD care to this vulnerable patient population.

Citing Articles

Cancer Screening in Renal Transplant Recipients: Real-World Data.

Al-Thnaibat M, Nser S, Alabdallat Y, Hajir M World J Oncol. 2024; 15(4):592-597.

PMID: 38993250 PMC: 11236365. DOI: 10.14740/wjon1822.


Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study.

Abe M, Hatta T, Imamura Y, Sakurada T, Kaname S Clin Exp Nephrol. 2023; 27(6):528-541.

PMID: 37002509 PMC: 10192167. DOI: 10.1007/s10157-023-02338-w.


Trends in nephrology referral patterns for patients with chronic kidney disease: Retrospective cohort study.

Ghimire A, Ye F, Hemmelgarn B, Zaidi D, Jindal K, Tonelli M PLoS One. 2022; 17(8):e0272689.

PMID: 35951609 PMC: 9371302. DOI: 10.1371/journal.pone.0272689.


Healthcare professionals' perspectives on facilitators of and barriers to CKD management in primary care: a qualitative study in Singapore clinics.

Ramakrishnan C, Tan N, Yoon S, Hwang S, Foo M, Paulpandi M BMC Health Serv Res. 2022; 22(1):560.

PMID: 35473928 PMC: 9044787. DOI: 10.1186/s12913-022-07949-9.


Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study.

Zhang H, Zhu B, Chang L, Ye X, Tian R, He L BMC Nephrol. 2022; 23(1):95.

PMID: 35247964 PMC: 8897863. DOI: 10.1186/s12882-022-02711-z.